✦ LIBER ✦

Docetaxel + Cisplatin (DC) and Docetaxel + Carboplatin (DCb) vs Vinorelbine + Cisplatin (VC) in chemotherapy-naïve patients with advanced and metastatic non-small cell lung cancer (NSCLC): Results of a multicenter, randomized phase III study

✍ Scribed by F. Fossella

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A multicenter, randomized phase III stud

✍ Belani, C.P; Rodriguez, J; von Pawel, J; Pluzanska, A; Gorbounova, V; Millward, 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 98 KB

P-452 Phase III study of docetaxel-cispl

✍ Belani, C.; von Pawel, J.; Pluzanska, A.; Gorbounova, V.; Kaukel, E.; Mattson, K 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

O-51 Phase III study (TAX 326) of doceta

✍ Belani, Chandra P.; Fossella, Frank V. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 180 KB

776 An economic analysis of the TAX 326

✍ N. Leighl; F.A. Shepherd; W.S. Tsao; P. Lindgren; C.B. Belani; F.V. Fossella; P. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 336 KB

Docetaxel Versus Docetaxel/Cisplatin in

✍ V. Georgoulias; A.G. Pallis; C. Kourousis; A. Alexopoulos; A. Ardavanis; A. Agel 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 150 KB

Cisplatin-vindesine-mitomycin (MVP) vs c

✍ Baldini, E; Tibaldi, C; Ardizzoni, A; Salvati, F; Antilli, A; Portalone, L; Barb 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 683 KB